S.E.E.D. Planning Group LLC Bristol Myers Squibb CO Transaction History

S.E.E.D. Planning Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	SELL	$57.89 - $64.73 $3,415 - $3,819	-59 Reduced 1.57%	3,691 $214,000
Q2 2023 Jul 18, 2023	BUY	$63.71 - $70.74 $6,944 - $7,710	109 Added 2.99%	3,750 $239,000
Q1 2023 Apr 13, 2023	BUY	$65.71 - $74.53 $2,694 - $3,055	41 Added 1.14%	3,641 $252,000
Q4 2021 Jan 24, 2022	BUY	$53.63 - $62.52 $193,068 - $225,072	3,600 New	3,600 $224,000
Q3 2021 Oct 21, 2021	SELL	$59.17 - $69.31 $183,071 - $214,445	-3,094 Closed	0 $0
Q2 2021 Jul 14, 2021	BUY	$61.91 - $67.42 $191,549 - $208,597	3,094 New	3,094 $207,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of S.E.E.D. Planning Group LLC, based on Form 13F filings with the SEC.

Stay updated on S.E.E.D. Planning Group LLC with notifications on news.